CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 42  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0838
LYS 10.0357
GLU 20.0209
LEU 30.0146
ARG 40.0140
CYS 50.0113
GLN 60.0248
CYS 70.0558
ILE 80.0697
LYS 90.0838
THR 100.0343
TYR 110.0232
SER 120.0245
LYS 130.0238
PRO 140.0186
PHE 150.0122
HIS 160.0031
PRO 170.0069
LYS 180.0086
PHE 190.0095
ILE 200.0097
LYS 210.0197
GLU 220.0111
LEU 230.0048
ARG 240.0238
VAL 250.0236
ILE 260.0170
GLU 270.0088
SER 280.0137
GLY 290.0539
PRO 300.0727
HIS 310.0239
CYS 320.0121
ALA 330.0347
ASN 340.0199
THR 350.0196
GLU 360.0139
ILE 370.0079
ILE 380.0112
VAL 390.0078
LYS 400.0102
LEU 410.0148
SER 420.0174
ASP 430.0237
GLY 440.0216
ARG 450.0159
GLU 460.0104
LEU 470.0185
CYS 480.0233
LEU 490.0078
ASP 500.0073
PRO 510.0174
LYS 520.0230
GLU 530.0184
ASN 540.0248
TRP 550.0156
VAL 560.0135
GLN 570.0139
ARG 580.0112
VAL 590.0045
VAL 600.0091
GLU 610.0114
LYS 620.0098
PHE 630.0136
LEU 640.0157
LYS 650.0197
ARG 660.0190
ALA 670.0213
GLU 680.0234
ASN 690.0795

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.